Cnudde Anthony, Allely Camille, Biset Natacha, Champy Pierre, Fouilhé Nathalie, Huret Fanny, Lawson Sibi, Mercan Aline, Noukela Noumi Doris Pascale, Michalet Serge, Montis Andrea, Pochet Stephanie, Schils Audrey, Tangeten Cecilia, Tod Michel, Van Antwerpen Pierre, Vervacke Audrey, Souard Florence
Department of Pharmacotherapy and Pharmaceutics, Faculty of Pharmacy, Université libre de Bruxelles (ULB), Brussels, Belgium.
Machine Learning Group, Faculty of Sciences, Université libre de Bruxelles (ULB), Brussels, Belgium.
BMC Complement Med Ther. 2024 Dec 18;24(1):414. doi: 10.1186/s12906-024-04706-9.
While more and more people tend to use herbal products thinking they are safer than conventional western medicine, the reality is other. If natural products are bio-active and possess potential therapeutic activities, then the benefit/risk balance should be considered like any other health product. Some herbs are known to have the potential to interact with patient's treatment and to cause adverse drug reactions. While these are scarce, they are potentially harmful, and can lead to major sequels and even death in some cases. Despite these known facts, little guidelines about how to evaluate the risk of interaction and to handle them exist in literature. Notably, few scales allowing to assess the risk of a specific combination of herbs and drugs exist.
We propose a new scoring method BABINE (Boosting Analysis of Bibliography for herb- drug INteraction Evaluation) and discuss a scale to evaluate this risk based on iterative rounds of experts' discussion.
After 6 rounds of case reports/clinical studies evaluation, we analyzed and synthesized criteria identified as important by the experts and developed a corresponding evaluation scale.
Even if our scale greatly simplifies pharmacological events, we believe it provides a robust and transparent way to rapidly assess the risk of adverse event.
虽然越来越多的人倾向于使用草药产品,认为它们比传统西药更安全,但实际情况并非如此。如果天然产品具有生物活性并具有潜在的治疗活性,那么就应该像对待任何其他健康产品一样考虑其利弊平衡。已知一些草药有可能与患者的治疗产生相互作用并引起药物不良反应。虽然这些情况很少见,但它们具有潜在危害,在某些情况下可能导致严重后果甚至死亡。尽管有这些已知事实,但文献中关于如何评估相互作用风险以及如何处理这些风险的指南却很少。值得注意的是,几乎没有可用于评估草药与药物特定组合风险的量表。
我们提出了一种新的评分方法BABINE(用于草药 - 药物相互作用评估的文献增强分析),并基于专家的多轮讨论,探讨了一种评估这种风险的量表。
经过6轮病例报告/临床研究评估后,我们分析并综合了专家确定为重要的标准,并制定了相应的评估量表。
即使我们的量表极大地简化了药理事件,但我们认为它提供了一种可靠且透明的方法来快速评估不良事件的风险。